[go: up one dir, main page]

SG11201608124XA - Pharmaceutical composition for external use - Google Patents

Pharmaceutical composition for external use

Info

Publication number
SG11201608124XA
SG11201608124XA SG11201608124XA SG11201608124XA SG11201608124XA SG 11201608124X A SG11201608124X A SG 11201608124XA SG 11201608124X A SG11201608124X A SG 11201608124XA SG 11201608124X A SG11201608124X A SG 11201608124XA SG 11201608124X A SG11201608124X A SG 11201608124XA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
external use
external
pharmaceutical
composition
Prior art date
Application number
SG11201608124XA
Inventor
Kazuyoshi Ado
Kozue Imai
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of SG11201608124XA publication Critical patent/SG11201608124XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11201608124XA 2014-03-30 2015-03-26 Pharmaceutical composition for external use SG11201608124XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014070679A JP6580306B2 (en) 2014-03-30 2014-03-30 Pharmaceutical composition for external use
PCT/JP2015/059327 WO2015151991A1 (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Publications (1)

Publication Number Publication Date
SG11201608124XA true SG11201608124XA (en) 2016-11-29

Family

ID=54240317

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608124XA SG11201608124XA (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Country Status (6)

Country Link
JP (1) JP6580306B2 (en)
CN (1) CN106413700B (en)
MY (1) MY192061A (en)
SG (1) SG11201608124XA (en)
TW (1) TWI684448B (en)
WO (1) WO2015151991A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113194938A (en) * 2018-12-19 2021-07-30 美德阿利克斯株式会社 External-use anti-inflammatory analgesic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5976013A (en) * 1982-10-23 1984-04-28 Toko Yakuhin Kogyo Kk Gelatinous pharmaceutical for surgical use
WO1992007561A1 (en) * 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Antiphlogistic and analgesic gel preparation
JPH07285887A (en) * 1994-04-15 1995-10-31 Oishi Kouseidou:Kk Base for plaster
JP4275751B2 (en) * 1996-12-27 2009-06-10 久光製薬株式会社 Composition for external use
CH699814B1 (en) * 2007-05-14 2010-05-14 Mepha Ag Diclofenac for topical application as a spray.
UA97529C2 (en) * 2007-06-08 2012-02-27 Троикаа Фармасьютикалс Лтд. Novel non-aqueous topical diclofenac solution and a process for preparing the same
EP2398459B1 (en) * 2009-01-30 2018-10-17 Kydes Pharmaceuticals, Llc Transdermal delivery of diclofenac, carbamazepine and benzydamine
JP2014101338A (en) * 2012-11-22 2014-06-05 Japan Medic Kk Anti-inflammation and analgesic topical medicament
JP6738120B2 (en) * 2013-03-29 2020-08-12 小林製薬株式会社 External pharmaceutical composition

Also Published As

Publication number Publication date
CN106413700A (en) 2017-02-15
JP2015189761A (en) 2015-11-02
TW201622713A (en) 2016-07-01
TWI684448B (en) 2020-02-11
JP6580306B2 (en) 2019-09-25
CN106413700B (en) 2020-06-02
MY192061A (en) 2022-07-25
WO2015151991A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
ZA201605300B (en) Pharmaceutical compositions comprising azd9291
GB201618482D0 (en) Pharmaceutical compositions
GB201419257D0 (en) Pharmaceutical compositions
GB201402277D0 (en) Pharmaceutical compounds
GB201409471D0 (en) Pharmaceutical composition
IL249553A0 (en) Pharmaceutical compositions
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
GB201409488D0 (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
GB201416513D0 (en) Pharmaceutical compounds
GB201417707D0 (en) Pharmaceutical compounds
ZA201702086B (en) Long acting pharmaceutical compositions
ZA201508726B (en) Pharmaceutical composition
ZA201502073B (en) Pharmaceutical composition
IL250817A0 (en) Pharmaceutical compositions
PL3200772T3 (en) Pharmaceutical compositions comprising alpelisib
LT3089740T (en) Pharmaceutical composition
SG11201608123VA (en) Pharmaceutical composition for external use
SG10201504332VA (en) Pharmaceutical Composition
SG11201608124XA (en) Pharmaceutical composition for external use
SG11201608122PA (en) Pharmaceutical composition for external use
SG2014014872A (en) Pharmaceutical compositions
GB201408432D0 (en) Pharmaceutical compositions
GB201416969D0 (en) Pharmaceutical compounds
GB201416968D0 (en) Pharmaceutical compounds